Page last updated: 2024-09-05
sb 203580 and apyrase
sb 203580 has been researched along with apyrase in 1 studies
Compound Research Comparison
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (apyrase) | Trials (apyrase) | Recent Studies (post-2010) (apyrase) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 1,997 | 16 | 833 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Giacobbe, E; Leoncini, G; Signorello, MG | 1 |
Other Studies
1 other study(ies) available for sb 203580 and apyrase
| Article | Year |
|---|---|
Activation by 2-arachidonoylglycerol of platelet p38MAPK/cPLA2 pathway.
Topics: Apyrase; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Endocannabinoids; Glycerides; Humans; Imidazoles; In Vitro Techniques; Indomethacin; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Phospholipases A2, Cytosolic; Phosphorylation; Piperidines; Pyrazoles; Pyridines; Reactive Oxygen Species; Rimonabant; Signal Transduction | 2011 |